Page 5 - Dr Reddy's Laboratories Limited
Fag-end buying in IT, banks lifts Sensex 831 pts at 60,138, Nifty at 17,930
The broader markets also logged strong gains, with the Midcap index up 1.8 per cent and the Smallcap index adding up 1.1 per cent
 "Fag-end buying in IT, banks lifts Sensex 831 pts at 60,138, Nifty at 17,930")
Dr Reddy's Laboratories working on enhancing Covid-19 portfolio
As for MSD's drug Molnupiravir, which is currently undergoing clinical trial in India, the company said it has already shared interim data with the drug regulator
 "Dr Reddy's Laboratories working on enhancing Covid-19 portfolio")
Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
Dr Reddy's global generic business grew 19 per cent YoY to Rs 4,743 crore driven by covid portfolio, new product launches and base business volume traction across key markets.
 "Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand")
Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule
Dr Reddy's Laboratories on Tuesday said it has received approval from the US health regulator to market Lenalidomide capsules
 "Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule")
Dr Reddy's Laboratories, Zydus Pharma recall products in US market
Dr Reddy's Laboratories, Inc, the US arm of Dr Reddy's Laboratories, is recalling 37,560 bottles of Tizanidine HCl tablets, USP 4 mg
India's worst-performing stock in July may rebound if history is any guide
Shares of pharma firm Dr Reddy's Labs have rallied about 15% after losing steam
 "India's worst-performing stock in July may rebound if history is any guide")
DRDO to get 2% royalty from Dr Reddy's on sale of Covid drug 2-DG in India
The drug comes in powder form in sachet and is taken orally by dissolving it in water.
Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months
Alembic Pharma and Dr Reddy's Labs plunged 12% and 11%, respectively in intra-day trade post their June quarter results
 "Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months")
Sputnik V soft launched in over 50 cities in India: Dr Reddy's Laboratories
Dr Reddys Laboratories Ltd, which soft-launched Russia's Covid-19 vaccine, Sputnik V here on May 14 has expanded the pilot project to over 50 other cities and towns in the country
 "Sputnik V soft launched in over 50 cities in India: Dr Reddy's Laboratories")
Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
Dr. Reddy's had received about 3 million first doses by June 1 and about 360,000 doses of the second by early this month, the company and the Indian government have said
Nifty outlook & trading ideas by HDFC Sec: Buy Bajaj Finance, Dr Reddy's
Bajaj Finance's stock price has broken out from symmetrical triangle on the daily charts, and rising volumes have confirmed the breakout
 "Nifty outlook & trading ideas by HDFC Sec: Buy Bajaj Finance, Dr Reddy's")
Dr Reddy's bullish on OTC products sale through Amazon, others in US
Dr Reddy's first began selling its OTC Habitrol brand nicotine patches on Amazon in 2016, as an experiment.
Sensex, Nifty post fourth straight weekly rise; Dr Reddy's rises over 3%
After rising 341 points, the Sensex settled 174 points, or 0.33 per cent, higher at 52,475
 "Sensex, Nifty post fourth straight weekly rise; Dr Reddy's rises over 3%")
Hyderabad's Rockwell collaborates with Dr Reddy's Lab for Sputnik V rollout
Rockwell Industries has got orders for 750 Covid19 vaccine freezers from hospitals and institutions.
 "Hyderabad's Rockwell collaborates with Dr Reddy's Lab for Sputnik V rollout")
Dr Reddy's lines up Rs 1,000 cr capex for current fiscal on growth outlook
Dr Reddy's Laboratories has earmarked a Capex of around Rs 1,000 crore for the current fiscal as it remains positive about sustaining its growth trends in the current fiscal, top company official said
 "Dr Reddy's lines up Rs 1,000 cr capex for current fiscal on growth outlook")
Shilpa Medicare jumps 26% in 2 days on tie-up with DRL for Covid vaccine
The company has entered into a three-year Definitive Agreement with Dr. Reddy's for production-supply of the Sputnik V vaccine
 "Shilpa Medicare jumps 26% in 2 days on tie-up with DRL for Covid vaccine")
Russia's Sputnik V vaccine for Covid priced at Rs 948 plus 5% GST in India
Inoculation could be cheaper when it is manufactured domestically, says Hyderabad company.
 "Russia's Sputnik V vaccine for Covid priced at Rs 948 plus 5% GST in India")
Expert panel recommends approval to Russia's Sputnik V Covid-19 vaccine
Now, the Drugs Controller General of India DCGI will consider this recommendation and decide whether to grant Sputnik V approval for restricted emergency use in India
 "Expert panel recommends approval to Russia's Sputnik V Covid-19 vaccine")
Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs
Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade
 "Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs")
Dr Reddy's Labs terminates Kuwait-based Covid-19 treatment study
Dr Reddy's Laboratories on Wednesday announced termination of Avigan trial study being conducted in Kuwait
 "Dr Reddy's Labs terminates Kuwait-based Covid-19 treatment study")